Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Aldeyra Therapeutics Receives Complete Response Letter From FDA; Says Additional Trial Required To Demonstrate Positive Effect On The Treatment Of Ocular Symptoms In Dry Eye Disease

Author: Benzinga Newsdesk | November 27, 2023 05:08pm

Posted In: ALDX